AI in Health: Loris, Roche Brasil with Laura Velasquez of Arkangel AI on data-driven care
Roche & Arkangel AI use data to improve diagnosis, access, and equity in Latin America
Artificial Intelligence in Health: Arkangel AI and Roche’s Path Forward
Explore how Arkangel AI and Roche are advancing artificial intelligence in health, with a focus on data-driven diagnosis and equitable access to care in Latin America.
Precision, Prevention, and Progress: How Roche and Arkangel AI Are Shaping the Future of Artificial Intelligence in Health
This episode features Laura Velasquez (Arkangel AI) and Loris (Roche Brasil), unpacking the transformative impact of artificial intelligence in health and Roche’s strategy to bridge systemic gaps in care.
Summary
Laura Velasquez of Arkangel AI speaks with Loris, Roche Brasil’s leader, about leveraging artificial intelligence in health to solve challenges in access, efficiency, and personalization within the region’s evolving health infrastructure. With expertise from Arkangel AI and Roche, they discuss concrete strategies for data-driven transformation across public and private care systems.
Episode at a Glance
- Guests: Loris — Country Lead, Roche Brasil
- Topics: Health data in decision-making, innovation in diagnosis, digital access gaps, interoperability, leadership for AI adoption
- Why it matters for artificial intelligence in health: Addressing system inefficiencies and late diagnoses with the combined expertise of Arkangel AI and Roche creates actionable blueprints for scalable, equitable impact in Latin America.
Overview
The pressure on health systems in Latin America continues to rise with growing populations and chronic underinvestment in digital infrastructure. In this episode, host Laura Velasquez of Arkangel AI and guest Loris of Roche Brasil shed light on how artificial intelligence in health and robust data integration are poised to replace legacy processes, short-circuit inefficiencies, and reshape patient journeys across diverse regions.
By unpacking the practical interplay between diagnostic accuracy and timely intervention—Roche’s specialty—and Arkangel AI’s mission to maximize accessible, predictive care, this conversation offers unique insight into how AI-powered innovations align with pressing real-world needs. Listeners gain perspective on bridging rural/urban access divides, advancing regulatory standards, and fostering a universal sense of urgency and responsibility among public and private health actors.
Key Takeaways
- Digital health data and AI solutions enable earlier disease detection and tailored interventions.
- Legacy systems and paper-based workflows slow patient access and perpetuate inequity.
- Collaboration between public and private sectors, like Roche’s model, accelerates scalable innovation.
- Leadership and transparency are essential to overcome resistance and deploy interoperable AI in health.
Chapter Markers
- [00:00] Power of data connection in health
- [05:12] From legacy diagnostics to scalable AI-driven solutions
- [14:37] Access, adoption, and training for digital transformation
- [22:09] Equity, bias, and building trust in health data
Notable Ideas
- “Artificial intelligence in health is not tomorrow’s solution—it’s today’s, if we wield data well.” — Loris, Roche Brasil
- “To create meaningful change, we must stop solving today’s health crises with yesterday’s tools.” — Laura Velasquez, Arkangel AI
- “Genuine innovation isn’t just product—it’s how we work, collaborate, and drive alternatives.” — Loris, Roche Brasil
Why This Matters
Clinicians and health-system decision-makers increasingly face inefficiencies and resource bottlenecks that threaten patient outcomes. Artificial intelligence in health, when embedded with effective data governance and interoperability—like examples from Roche Brasil—enables streamlined diagnostics, proactive care, and more accurate population health management. This episode highlights practical levers for medical staff and administrators to act on current opportunities, not future hypotheticals.
For medical-affairs teams and public health leaders, the conversation surfaces real-world models for closing the gap between breakthrough science and operational reality. By driving adoption and collaboration between companies such as Arkangel AI and Roche, the Latin American region can realize equitable, timely, and truly transformative healthcare interventions for all patients.
About Arkangel AI
Arkangel AI pioneers actionable solutions in artificial intelligence in health, bridging evidence-driven technology with urgent local needs in Latin America and beyond. Through partnerships, research, and products that prioritize equity and clinical accuracy, Arkangel AI empowers healthcare providers, systems, and patients to make smarter, faster, and more inclusive decisions for optimal outcomes. Learn more at www.arkangel.ai or connect with international peer networks at Future Health Index.
FAQ
Q: How is Roche Brasil using artificial intelligence in health to improve patient outcomes?
A: Roche Brasil leverages AI for clinical trial design, early diagnosis, and individualized treatment guidance—using health data to optimize timing and resource allocation for better patient results. By connecting diagnostics with scalable digital systems, Roche sets practical benchmarks in regional care transformation.
Q: What is the first step for healthcare systems to implement artificial intelligence effectively?
A: The episode emphasizes establishing data interoperability and clear regulatory frameworks as critical first steps. Both Arkangel AI and Roche advise building clean, accessible health databases across public and private sectors—making reliable AI-driven solutions possible for clinicians and leaders alike.
Q: How can addressing bias in health data make AI more reliable?
A: By auditing for bias and correcting known limitations—such as gender disparities—organizations like Roche can ensure AI models better reflect diverse patient populations. Transparent, proactive management of data equity is fundamental to trust and efficacy.
Q: Where can professionals learn more about current AI health innovations?
A: Beyond Arkangel AI’s resources, leaders are encouraged to follow global platforms like HealthIT.gov and Roche’s global insights for updates, evidence, and collaboration opportunities.